Editas Medicine (EDIT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
17 Jun, 2026Opening remarks and agenda
Meeting called to order by the Chair, held in an all-virtual format to ensure equal participation rights for all stockholders.
Introductions included board members, senior management, independent auditor, and Inspector of Election.
Rules of conduct and confirmation of proper notice to stockholders were addressed.
Board and executive committee updates
Attendance included all directors, CEO, CFO, Chief Scientific Officer, General Counsel, and other senior leaders.
Shareholder proposals
Three proposals: election of two Class I directors, advisory vote on executive compensation, and ratification of the independent auditor.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Editas Medicine
- EDIT-401 aims for 90% LDL reduction, with first dosing this year and safety data in Q1 next year.EDIT
12th Annual Cantor Fitzgerald Global Healthcare Conference - EDIT-401, an in vivo CRISPR therapy for LDL reduction, enters clinical trials this year.EDIT
Wells Fargo 21st Annual Healthcare Conference - Shelf registration allows up to $400M in offerings, including $150M ATM sales for gene editing R&D.EDIT
Registration filing - EDIT-401 advances with robust preclinical data as net loss narrows and cash rises to $211.6M.EDIT
Q2 2026 - Pivoting to in vivo gene editing, with proof of concept achieved and cash runway to Q2 2027.EDIT
Strategy Update - In vivo gene editing and reni-cel partnership drive strategic focus, with strong financial runway.EDIT
Stifel 2024 Healthcare Conference - CRISPR-based LDLR upregulation shows 90% LDL reduction, with human trials set for 2026.EDIT
Evercore ISI 8th Annual HealthCONx Conference - Q2 net loss widened to $67.6M as R&D spending surged; cash runway extends into 2026.EDIT
Q2 2024 - Reniz-cel shows strong efficacy as the company advances in vivo editing and IP monetization strategies.EDIT
Morgan Stanley 22nd Annual Global Healthcare Conference